Central in Biological Technology

MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus

ROCKVILLE, Md. , July 13 /PRNewswire/ -- MacroGenics, Inc. today announced the initiation of the PARADIGM trial, a Phase 2 clinical study evaluating MGAWN1, a humanized monoclonal antibody, for the treatment of individuals with suspected central nervous system infection due to West Nile Viru...

ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand

DUBLIN, June 26 /PRNewswire-FirstCall/ -- - Singapore Laboratory Testing Increases by 149% in Past Six Months ICON plc (NASDAQ:ICLR: ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today...

Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition

Simulation-based program helps healthcare providers build competence and confidence while keeping infections at bay DENVER, May 11 /PRNewswire/ -- Medical Simulation Corporation ( MSC ) will launch the SimSuite Central Line Management Program at AACN's National Teaching Institute (NTI) an...

ACM Global Central Lab Announces Partnership with Chindex's United Family Hospitals in China

ROCHESTER, N.Y., YORK, England and BETHESDA, Md., April 1 /PRNewswire-Asia/ -- ACM Global Central Laboratory, the laboratory that continually defines the client-service standard with its inherently flexible approach, and Chindex International, Inc. (Nasdaq: CHDX ), today announced a partners...

Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse

Pilot Program in Fort Lauderdale helps to Leverage Bio-Tech Medical Software, Inc. with the University of Central Florida. Bio-Tech Medical Software, Inc., will utilize UCF's biometrics, elite technology and other programming techniques in an effort to establish the best prescription monitoring pr...

Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia

BOZEN, Italy, February 23 /PRNewswire/ -- Health Robotics and Can-Med today announced that they have signed a definitive agreement whereby Can-Med has acquired the exclusive distribution rights to Health Robotics' i.v.STATION robot in Armenia, Georgia, Kazakhstan, Uzbekistan, Azerbaijan, Iran,...

Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany

NORDHAUSEN, Germany, Jan. 26 /PRNewswire-FirstCall/ -- Three prostate cancer patients have become the first people in Germany to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Sudharz...

ICON Opens Full Service Central Laboratory in India

Expands Global Laboratory Network to Meet Market Demands for Global Trials DUBLIN, November 12 /PRNewswire-FirstCall/ -- ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today ann...

PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies

BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, today announced that it is expanding its clinical pharmacology capabilities in the Central Nervous System (CNS) therapeutic area. PAREXEL is enhan...

Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China

SCHAUMBURG, Ill., May 14 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it will contribute US$20,000 to the American Red Cross to assist the victims of Monday's earthquake in central China. "As a part of the global commun...

Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance

VANCOUVER, April 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its innovative...

PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business

BOSTON, April 2, 2008 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services organization, today announced that Larry Ereshefsky, Pharm.D., F.C.C.P., B.C.C.P., and Malek Bajbouj, M.D., have been appointed as Vice Presidents of ...

960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter

Study Successfully Hit Primary End Point of Preventing Bacterial Colonization with a Trend Toward Superiority over the Market Leader VANCOUVER, March 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical devic...

PPD Expands Global Central Lab Services into China

WILMINGTON, N.C., Jan. 23 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced that it has expanded its global central lab services into China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited (PUL). The agreement allows PPD to begin immediatel...

Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility

RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles Transnational Corp. today announced the expansion and consolidation of its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to accommodate their growing business in China. The new consolidated ...

Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean

WILMINGTON, N.C., Nov. 27 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Jose Luis Viramontes, M.D., as associate director of clinical operations, to lead the company's delivery of drug development services in Mexico, Central America and the Caribbean. Ba...

MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO

Union Springs Pharmaceutical launches the only non-alcohol first response protection product that can be sprayed on the face. ORLANDO, Fla., Oct. 10 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today at the annual EMS EXPO that it is marketing a new revolutionary produ...

Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial

VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it intends to file Premarket Notification 510(k) documents with the U.S. Food and Drug Administration (FDA) ...

Vet-Stem and Central Veterinary Research Labs of Dubai Sign Exclusive License

SAN DIEGO, Sept. 13 /PRNewswire/ -- Vet-Stem, Inc., the global leader in regenerative veterinary medicine, has licensed their proprietary stem cell technology to the Central Veterinary Research Laboratory (CVRL) of Dubai in the United Arab Emirates. The license allows the laboratory to offer a...

Medpace Strengthens Presence in Central Europe

CINCINNATI and PRAGUE, Czech Republic, Aug. 21 /PRNewswire/ -- Medpace, Inc., a leading global full-service contract research organization, today announced it has completed the acquisition of Monax s.r.o., a regional contract research organization (CRO) headquartered in Prague, Czech Republic....

Weather Central launches second satellite

MADISON - Weather Central Inc. , rather than relying on existing telecommunications satellites, has put a second satellite into service so that it can provide redundancy to its weather information clients. Last September, Loral Skynet announced the Telstar 4 satellite had short-circuited a...

Norlight to expand fiber network into central Illinois

Milwaukee Norlight Telecommunications Inc. plans to extend its network into central Illinois by activating fiberoptic cable. The company says it operates 3,800 miles of network connections already and will add 347 miles more later this year. The Illinois expansion plans cover Peoria, Bloomi...

Will wireless Internet bypass the central city?

Milwaukee, Wis - For Milwaukee's forthcoming wireless Internet service, everything seems to be set. The City of Milwaukee has finalized a contract with Midwest Fiber Networks, LLC to build a citywide wireless Internet network. Taxpayers are off the hook because Midwest Fiber will invest t...

Madison start-up Central Signal gets $350K grant

Madison, Wis. - Central Signal, LLC, a Madison based company, has been awarded a $350,000 grant from the United States Department of Agriculture . The SBIR Phase II research grant will be used to develop a prototype and conduct additional tests on a magnetic sensor that would be used to detec...

Meterologix Media Division acquired by Madison-based Weather Central

MADISON Weather Central, Inc. , a provider of weather graphics systems and related media services, announced Monday it has acquired the media division of Meteorlogix , based in Burnsville, Minn. All Meteorlogix Media Division products including the new X television weather graphics system, R...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...device is used for the processing of cord blood. GE Healthcare is the exclusive global distribution partner for the AXP cord blood product except for central and South America, China and Russia/CIS, where ThermoGenesis markets through independent distributors. The MXP is used for isolating stem cells from ...

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

... development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the q... development and commercialization of clinical-stage product candidates for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please v...

ThermoGenesis Provides Update on Fiscal 2009 Results

...device is used for the processing of cord blood. GE Healthcare is the exclusive global distribution partner for the AXP cord blood product except for central and South America, China and Russia/CIS, where ThermoGenesis markets through independent distributors. The MXP is used for isolating stem cells from ...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... Information On Thursday, August 6, 2009, at 8:30 a.m. Eastern/2:30 p.m. central European/5:30 a.m. Pacific, members of CTI's management team will host a qu...ference Call Numbers Thursday, August 6 8:30 a.m. Eastern/2:30 p.m. central European/5:30 a.m. Pacific Time 1-877-941-9205 (US Participants) 1-...

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

...tic(TM) which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www...

Omeros Appoints New Vice President of Clinical Development

... Murray. "In addition, we have several preclinical central nervous system and inflammation programs that have...armaceutical company that developed treatments for central nervous system disorders and was acquired by Hoffm...ducts focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced p...

Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit

...ny unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and on... the Benelux countries, and Poland for Eastern and central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... SUPPRELIN ((R)) LA: SUPPRELIN LA is indicated for the treatment of central precocious puberty (CPP). Endo recently launched a new web site (www.suppl...ive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM(R), a topical patch...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...arket at that time. Also contributing to EMEA revenues were sales from the central and Eastern European businesses, which Mylan acquired from Merck KGaA in Ju...ew product launches, and a full six months of revenue contribution from the central and Eastern European businesses served to offset lower revenues brought abo...

Neurocrine Biosciences Reports Second Quarter 2009 Results

...as clinically meaningful efficacy coupled with a favorable safety profile. The Tulip Petal Study (0703) has completed subject randomization in central Eastern Europe (n=174). This study is designed as a randomized, double-blind, placebo and active controlled trial with four treatment arms; elagolix 1...

Nanotech particles affect brain development in mice

... Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose m...

Breaking barriers with nanoscale lasers

...plications, but the most exciting possibilities are for communications on a central processing unit (CPU) of a computer chip," Ning says. As computers get ... being funded by the Defense Advanced Research Projects Agency (DARPA), the central research and development organization for the U.S. Department of Defense. T...

Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division

... Dr. Pilest, a Board Certified Dermatologist, will carry out the trials at his medical and cosmetic dermatology clinic, Total Dermatology, located in central Irvine. His 30 year career in dermatological surgery, medical dermatology and cosmetic anti-aging brought him to the attention of SDS Clinical Trials...

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

...t target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including genetic disorders, oncol...

Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009

..., August 6, 2009, at 9:00 am Eastern Time (3:00 pm central European Time) to discuss its financial results fo...financial results at 7:00 am Eastern Time (1:00 pm central European Time) on Thursday, August 6, 2009. ...m 12:00 pm Eastern Time on August 6, 2009 (6:00 pm central European Time) through Thursday, August 13, 2009. ...